Please login to the form below

Not currently logged in
Email:
Password:

Virginia Acha leaves Amgen for ABPI

Joins UK pharma trade body as director of research, medical and innovation

ABPI, Virginia AchaTrade body the Association of the British Pharmaceutical Industry (ABPI) has appointed Amgen director Virginia (Ginny) Acha as executive director in charge of research, medical and innovation.

Dr Acha is currently director of global regulatory and R&D policy across the EMEA region for Amgen, a role she has held for two years after joining the company from Pfizer.

She spent five years at Pfizer including periods as government affairs manager in the UK and director of international policy.

Dr Acha will take up her position at the ABPI in March at what will be a key time for the UK life sciences industry with the general election set to take place in May.

“These are exciting times in the science, development and delivery of medicines, and so it is a great privilege to be joining the ABPI now to help deliver our industry's views and aspirations for the future of healthcare,” she said.

In addition to her experience in the pharma industry Dr Acha has had an extensive career in academia holding posts at Imperial College London Business School, the Science Policy Research Unit (SPRU) at the University of Sussex and the Centre for Research in Innovation Management (CENTRIM) at the University of Brighton.

She is currently a visiting researcher in the innovation and entrepreneurship department at Imperial College Business School London.

27th January 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics